- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
New classification of cancers based on transposon expression patterns: A trial in neuroblastoma stages 4 and 4S
-
- Yamada Shiro
- Department of Pediatrics, Oiso Hospital, Tokai University
-
- Ito Jumpei
- Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo
-
- Hayano Takahide
- Department of Systems Bioinformatics, Graduate School of Medicine, Yamaguchi University
-
- Nakaoka Hirofumi
- Human Genetics Laboratory, National Institute of Genetics
-
- Kimura Tetsuaki
- Human Genetics Laboratory, National Institute of Genetics
-
- Sugimoto Ryota
- Human Genetics Laboratory, National Institute of Genetics
-
- Mochizuki Hiroyuki
- Department of Pediatrics, Tokai University School of Medicine
-
- Inoue Ituro
- Human Genetics Laboratory, National Institute of Genetics
Bibliographic Information
- Other Title
-
- トランスポゾンによる悪性腫瘍の新しい分類の可能性
- ~神経芽腫ステージ4Sに着目して~
Search this article
Description
<p>Transposable elements (TEs) are “DNA parasites” of the genome, which transpose, proliferate and comprise about 45% of the human genome. The transposition of TEs may harm the genome with the destruction of genes, thereby causing diseases. However, TEs have transcription factor binding sites (TFBSs), and a substantial fraction of them act as enhancers for nearby genes. Thus, TEs are required for genome functions. The adaptational capability of the genome is supported by the flexible use of TFBSs derived from TEs, called “exaptation”. Given that active enhancers are transcribed to RNA, transcribed TEs may reflect part of the “enhancer landscape” of cells. Neuroblastomas (NBs) have a unique stage called 4S in which they regress spontaneously even if stage 4 (st4) shows poor prognosis. A comparison study of st4 and 4S may provide the keys to finding the causes underlying the malignant characteristics of NBs and also the benign behavior of 4S. NBs show a relatively low frequency of gene mutations, so the amount of information obtained by studying NBs is limited. We introduced a method of TE transcriptome analysis, which may show another aspect of genome dysfunctions in TE-derived enhancer systems. Both gene and TE expression data have the power to cluster st4 and 4S clearly. They also brought about subclusters of st4, which show different survival courses. The significance of TE-based NB clusters will be revealed and would open a new age of medical discoveries.</p>
Journal
-
- The Japanese Journal of Pediatric Hematology / Oncology
-
The Japanese Journal of Pediatric Hematology / Oncology 56 (3), 293-303, 2019
The Japanese Society of Pediatric Hematology / Oncology
- Tweet
Details 詳細情報について
-
- CRID
- 1390564227347442944
-
- NII Article ID
- 130007747180
-
- ISSN
- 21895384
- 2187011X
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed